Literature DB >> 19115217

Sorafenib: A glimmer of hope for unresectable hepatocellular carcinoma?

Andrew Scanga1, Kris Kowdley.   

Abstract

Entities:  

Year:  2009        PMID： 19115217     DOI： 10.1002/hep.22756

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  3 in total

1.  Targeting of the Akt-nuclear factor-kappa B signaling network by [1-(4-chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol (OSU-A9), a novel indole-3-carbinol derivative, in a mouse model of hepatocellular carcinoma.

Authors:  Hany A Omar; Aaron M Sargeant; Jing-Ru Weng; Dasheng Wang; Samuel K Kulp; Tushar Patel; Ching-Shih Chen
Journal:  Mol Pharmacol       Date:  2009-08-25       Impact factor: 4.436

2.  Deciphering Antitumor Mechanism of Pien Tze Huang in Mice of Hepatocellular Carcinoma Based on Proteomics.

Authors:  Dancai Fan; Chang Liu; Li Li; Cheng Lu; Ning Zhao; Jun Shu; Xiaojuan He; Aiping Lu
Journal:  J Immunol Res       Date:  2020-12-03       Impact factor: 4.818

3.  Sirtuin 3 enhanced drug sensitivity of human hepatoma cells through glutathione S-transferase pi 1/JNK signaling pathway.

Authors:  Na-Na Tao; Hong-Zhong Zhou; Hua Tang; Xue-Fei Cai; Wen-Lu Zhang; Ji-Hua Ren; Li Zhou; Xiang Chen; Ke Chen; Wan-Yu Li; Bo Liu; Qiu-Xia Yang; Sheng-Tao Cheng; Li-Xia Huang; Ai-Long Huang; Juan Chen
Journal:  Oncotarget       Date:  2016-08-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.